158 related articles for article (PubMed ID: 19669642)
1. Tumors induce the formation of suppressor endothelial cells in vivo.
Mulligan JK; Young MR
Cancer Immunol Immunother; 2010 Feb; 59(2):267-77. PubMed ID: 19669642
[TBL] [Abstract][Full Text] [Related]
2. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.
Mulligan JK; Lathers DM; Young MR
Cancer Immunol Immunother; 2008 Jul; 57(7):951-61. PubMed ID: 18058097
[TBL] [Abstract][Full Text] [Related]
3. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.
Mulligan JK; Rosenzweig SA; Young MR
J Immunother; 2010; 33(2):126-35. PubMed ID: 20145550
[TBL] [Abstract][Full Text] [Related]
4. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
Mailloux AW; Young MR
J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells.
Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR
Cancer Immunol Immunother; 1996 May; 42(4):213-20. PubMed ID: 8665568
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
8. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
9. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
Mailloux AW; Clark AM; Young MR
Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623
[TBL] [Abstract][Full Text] [Related]
10. Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells.
Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR
Cancer Lett; 1995 Jun; 92(2):235-42. PubMed ID: 7600536
[TBL] [Abstract][Full Text] [Related]
11. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
Young MR; Wright MA
Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
[TBL] [Abstract][Full Text] [Related]
12. Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Endicott RA; Duffie GP; Wepsic HT
J Leukoc Biol; 1987 Dec; 42(6):682-8. PubMed ID: 3500255
[TBL] [Abstract][Full Text] [Related]
13. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
14. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.
Young MR; Young ME; Wright MA
Int J Cancer; 1990 Aug; 46(2):245-50. PubMed ID: 2143498
[TBL] [Abstract][Full Text] [Related]
15. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
16. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
Young MR; Wright MA; Matthews JP; Malik I; Prechel M
J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.
Young MR; Wright MA; Young ME
Cancer Immunol Immunother; 1991; 33(3):146-52. PubMed ID: 1675153
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
19. Changes in the activation and reconstitution of lymphocytes resulting from total-body irradiation correlate with slowed tumor growth.
Miller GM; Kim DW; Andres ML; Green LM; Gridley DS
Oncology; 2003; 65(3):229-41. PubMed ID: 14657597
[TBL] [Abstract][Full Text] [Related]
20. Decreased T-cell proliferation and skewed immune responses in LLC-bearing mice.
Rashid RM; Achille NJ; Lee JM; Lathers DM; Young MR
J Environ Pathol Toxicol Oncol; 2005; 24(3):175-92. PubMed ID: 16050802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
